GPC3-targeted CAR-NK cells have shown robust anti-tumor activity both in vitro and in vivo, displaying efficient tumor infiltration, suppression of cancer cell proliferation, and induction of apoptosis. The gene discussed is GPC3; the disease is neoplasm.